These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6376401)

  • 21. [Progress of chemotherapy in various fields--pediatrics].
    Sunakawa K
    Nihon Rinsho; 1986 Apr; 44(4):879-83. PubMed ID: 3761593
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.
    Ho JL; Barza M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):485-91. PubMed ID: 3300527
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-lactams with or without aminoglycosides.
    Alfandari S; Boussekey N
    Clin Infect Dis; 2005 Nov; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigation of the regioselectivity for the staudinger reaction and its application for the synthesis of aminoglycosides with N-1 modification.
    Li J; Chiang FI; Chen HN; Chang CW
    J Org Chem; 2007 May; 72(11):4055-66. PubMed ID: 17465564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New studies in the field of aminoglycosidic aminocyclitol antibiotics.
    Arcamone F; Bertazzoli C; Buogo A; Cassinelli G; Vigevani A
    Panminerva Med; 1974; 16(1-2):9-24. PubMed ID: 4449644
    [No Abstract]   [Full Text] [Related]  

  • 26. Aminoglycoside resistance.
    Phillips I; Shannon K
    Br Med Bull; 1984 Jan; 40(1):28-35. PubMed ID: 6100077
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacology of aminoglycoside antibiotics in pediatrics.
    Blumer JL; Reed MD
    Pediatr Clin North Am; 1983 Feb; 30(1):195-208. PubMed ID: 6338465
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibacterial activity of tobramycin].
    Acar JF
    Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro- and in vivo- studies with aminoglycosides].
    Ritzerfeld W
    Adv Clin Pharmacol; 1978; 15():13-21. PubMed ID: 676872
    [No Abstract]   [Full Text] [Related]  

  • 30. [New wave of antibiotics. II. Aminoglycosides, macrolides and prospects for the future].
    Sorin M
    Arch Fr Pediatr; 1982; 39(7):477-9. PubMed ID: 7149894
    [No Abstract]   [Full Text] [Related]  

  • 31. New antibiotics. New hopes and new problems.
    Eng RH
    Int J Dermatol; 1984 Apr; 23(3):153-65. PubMed ID: 6373637
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical pharmacology of the antimicrobial agents for infections in the ear, nose and throat.
    Neu HC
    Ann Otol Rhinol Laryngol Suppl; 1981; 90(3 Pt 3):2-7. PubMed ID: 6791559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside antibiotics in the treatment of otologic infections.
    Matz GJ; Lerner SA; Lanzl EF
    Otolaryngol Head Neck Surg; 1981; 89(5):705-9. PubMed ID: 6799892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of resistance to aminoglycosides in clinical isolates.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1982 Feb; 9(2):91-102. PubMed ID: 7037733
    [No Abstract]   [Full Text] [Related]  

  • 35. Aminoglycoside drugs in clinical practice: an evidence-based approach.
    Leibovici L; Vidal L; Paul M
    J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; GoĊ›ciniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prudent use of the aminoglycosides.
    Gregory D; Hirschmann JV
    Postgrad Med; 1978 Sep; 64(3):97-102, 104. PubMed ID: 704499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic usefulness of aminoglycosides. Why netilmicin?].
    Bossa R
    Clin Ter; 1985 Nov; 115(3):201-4. PubMed ID: 4085177
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing strategies in aminoglycoside dosing; the result of research on antimicrobial pharmacodynamics.
    Zhanel GG
    Zentralbl Bakteriol; 1993 Nov; 279(4):447-9. PubMed ID: 8305801
    [No Abstract]   [Full Text] [Related]  

  • 40. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides.
    Chen LF; Kaye D
    Infect Dis Clin North Am; 2009 Dec; 23(4):1053-75, x. PubMed ID: 19909897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.